On June 19, 2025, the Board of Directors of NeoGenomics, Inc. (the "Company") increased the size of the Board of Directors (the "Board") from nine to ten members and appointed Marjorie C. Green as a director to fill the vacancy resulting from that increase.
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
On June 17, 2025, the Board of Directors (the “Board”) of the Company appointed Hyunsu Jung to the position of Chief Investment Officer and to serve on the Board, effective immediately.
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
On June 24, 2025, J.Jill, Inc. (the “Company”) announced that Shelley Liebsch, the Company’s Senior Vice President, Chief Merchandising Officer, will be departing from the Company, effective July 1, 2025.
On June 24, 2025, Sprinklr, Inc. (the “ Company ”) announced that Scott Harvey, the Company’s Chief Customer Officer, will leave the Company on July 7, 2025.
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
on June 17, 2025, the Board appointed Bjarne Borg, James D. Burnham and Anthony M. Cialone, each of whom was designated by a majority in interest of the former members of Resource Group, as directors of the Company, in Classes I, III and II, respectively.
on June 17, 2025, the Board appointed Bjarne Borg, James D. Burnham and Anthony M. Cialone, each of whom was designated by a majority in interest of the former members of Resource Group, as directors of the Company, in Classes I, III and II, respectively.
On June 17, 2025, Paul M. Galvin (Class I Director) and Alyssa Richardson (Class III Director) each notified the Company of their decision to resign, effective immediately, from their position as a member of the Board.
On June 17, 2025, Paul M. Galvin (Class I Director) and Alyssa Richardson (Class III Director) each notified the Company of their decision to resign, effective immediately, from their position as a member of the Board.
On June 23, 2025, Yaniv Blumenfeld (Class III Director) notified the Company of his decision to resign, effective immediately, from his position as a member of the Board.
on June 17, 2025, the Board appointed Bjarne Borg, James D. Burnham and Anthony M. Cialone, each of whom was designated by a majority in interest of the former members of Resource Group, as directors of the Company, in Classes I, III and II, respectively.
On June 18, 2025, Richard J. Paolone and John L. Brooks III each resigned from the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”), effective immediately.
On June 18, 2025, Richard J. Paolone and John L. Brooks III each resigned from the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”), effective immediately.
Mr. Soistman has agreed to continue serving as chief executive officer and all other roles with its subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the “CEO Transition” and such period, the “Additional CEO Period”), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the “Transition Period”).
On June 18, 2025, Mario L. Giannini, Executive Co-Chairman of Hamilton Lane Incorporated (the “Company”), provided notice to the Board of Directors of the Company (the “Board”) that he does not intend to stand for re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders.
On June 24, 2025, the Board appointed Mr. Robert B. Waldner Jr. to serve as a director of the Company, effective as of that date, to fill the vacancy created by Ms. Zayicek’s departure.
Consistent with her announced departure, Ms. Zayicek did not seek re-election as an executive director at the 2025 Annual Meeting of the Stockholders which was held on May 6, 2025.
On June 23, 2025, David J. Mansfield notified the Board of Directors (the "Board") of Perma-Pipe International Holdings, Inc. (the "Company") of his resignation as a member of the Board, effective immediately, as well as his decision not to stand for re-election to the Board.
As of the date hereof, Mr. Krysler is no longer Pure’s Chief Financial Officer, though he remains an employee of Pure and will provide ongoing services to help ensure a smooth transition of his duties and responsibilities.
Departed
Peter H. Nielsen
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Principal Accounting Officer, Chairman of the Board
On June 20, 2025, Peter H. Nielsen notified the Board of Directors (the “Board”) of Bio-Path Holdings, Inc. (the “Company”) of his decision to resign as President, Chief Executive Officer, Chief Financial Officer, Treasurer, Principal Accounting Officer, Chairman of the Board, member of the Board and all committees of the Board on which he served for the Company.
On June 20, 2025, Heath Cleaver notified the Company of his decision to resign as a member of the Board and all committees of the Board on which he served.
On June 21, 2025, Aline Sherwood notified the Company of her decision to resign as a member of the Board and all committees of the Board on which she served.
On June 20, 2025, John E. Stokely notified the Board that he does not intend to stand for re-election at the Company’s 2025 annual meeting of stockholders
On June 24, 2025, the Board of Directors (the “Board”) of PayPal Holdings, Inc. (the “Company”) appointed Deirdre Stanley as a new member of the Company’s Board, effective June 24, 2025.
On June 18, 2025, Claudio Torres, who serves as the Vice Chairman of the Board of Directors of Sadot Group Inc. (the “Company”), was appointed as Chairman of the Board of Directors of the Company.
On June 24, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Amerant Bancorp Inc. (the “Company”) authorized increasing the size of the Board from ten (10) to twelve (12) members, and thereafter appointed Patricia (“Patty”) Morrison and Jack Kopnisky to serve as members of the Company’s Board, with such appointments to be effective as of the Effective Date.
On June 24, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Amerant Bancorp Inc. (the “Company”) authorized increasing the size of the Board from ten (10) to twelve (12) members, and thereafter appointed Patricia (“Patty”) Morrison and Jack Kopnisky to serve as members of the Company’s Board, with such appointments to be effective as of the Effective Date.
On June 24, 2025, Kenvue Inc. (the "Company") announced that Ellie Bing Xie, currently Kenvue’s Group President, Asia Pacific, will cease to serve in such role on July 14, 2025 (the “Asia Pacific Transition”).
On June 18, 2025, the Board approved the appointment of Mr. O’Leary as President and Chief Executive Officer on a permanent, non-interim basis, effective July 1, 2025.
Role change
Joseph D. Fisher
Chief Financial Officer and principal financial officer
upon the effective date of Mr. Bragg’s appointment to serve as Senior Vice President - Chief Financial Officer and principal financial officer, Joseph D. Fisher will relinquish his roles and responsibilities as Chief Financial Officer and principal financial officer, and retain the roles of President and Chief Investment Officer of the Company.
The Board of Directors of UDR, Inc. (the “Company”) has approved the appointment of David D. Bragg to serve as the Company’s Senior Vice President - Chief Financial Officer, and as principal financial officer for the purposes of the Company’s filings with the Securities and Exchange Commission and for all other purposes contemplated thereby.
Appointed
Craig Albright
Executive Vice President and Chief Financial Officer
John Wiley & Sons, Inc. (the “Company”) issued a press release today, June 23, 2025, announcing the appointment of Craig Albright as Executive Vice President and Chief Financial Officer, reporting to President and Chief Executive Officer, Matthew S. Kissner, effective June 26, 2025.
Role change
Chris Caridi
Senior Vice President, Chief Accounting Officer and Finance Transformation Leader
Mr. Chris Caridi, the Company's Interim Chief Financial Officer, will continue with the role of Senior Vice President, Chief Accounting Officer and Finance Transformation Leader.
Upon Mr. Farris’ retirement, the Board of Directors appointed Eugenia Crittenden “Crit” Luallen as Chairman of the Audit and Asset Quality Committee.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.